ImpactRx provides unique and leading edge insight into the impact of marketing and sales activities on physician treatment decisions.

The company’s metric – the new written prescription (NWRx) – is the most sensitive measure of physician prescribing behaviour in the industry. It tracks new prescriptions written by physicians for newly diagnosed patients, or those whom have had a change in prescription therapy. This is the segment of the market where prescribing behaviour is most likely to be influenced by promotion.

To gather this intelligence, ImpactRx maintains a network of over 3,000 physicians, representing a statistically robust sample of the industry’s most valuable customers. Indeed, high prescribing physicians account for up to 70% of industry business. Information is recorded in real-time via a personal digital assistant and a laptop computer immediately after each patient or representative encounter, thus providing a clear snapshot of physician behaviour on a daily basis.

Additionally, ImpactRx conducts primary research on physician behaviour and provides consultative services with its advanced analytics group. ImpactRx plans to expand its services internationally, as it will be building and developing physician networks in the European Union.